HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program. Masich AM, Gomes D, Higginson RT, Morgan Z, et al. AIDS 2023;37:1641-1642.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Masich AM, Gomes D, Higginson RT, Morgan Z, et al. HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program. AIDS 2023;37:1641-1642.
PMID: 37450631